After a quick start out the gates in 2012, the European Commission proceeded to carry out a lengthy review of its bioeconomy strategy – slamming the brakes on investor interest in EU biotechs developing solutions for the move to a low-carbon, zero-waste economy. Following several reports that suggested the bloc will miss internationally agreed sustainability targets, the EC now wants to speed up the switch to biobased production. Industry stakeholders presented a huge range of promising technologies at the EFIB, but are still awaiting the go-ahead.
First immunotolerant allogenic cell transplants revealed
Latest NewsResearchers for the first time have found a way to prevent immune rejection of allogenic iPSC-derived cell and tissue transplants.
Digital solutions to serialisation
BackgroundIts only been nine years since the first blockchain technology applications in finance were introduced. Big players are now working to use distributed computing to protect pharma logistics from counterfeit drugs. Unlike current Internet-based solutions, the decentralised blockchain network is immune to manipulation or hacks, as transactions can be verified, recorded, and coordinated autonomously without third-party involvement.
Mundipharma appoints Patrice Grand
AppointmentsMundipharma today announced the appointment of Patrice Grand to the position of European Director of Corporate Communications.
Arvelle Therapeutics raises $180m in Series A financing
Latest NewsSwiss newco Arvelle Therapeutics has baged a $180m (€159.1m) series A financing led by LSP. The company licenced the anti-epileptic candidate cenobamate (YKP3089) for $100m (€88.4m) upfront from SK Biopharmaceuticals.
Bio-plastics production grows to 7.5 million tonnes
Latest NewsThe market for bio-based building blocks and polymers showed moderate growth to 7.5 million tonnes in 2018 and will grow with a CGAR of 4% by 2023 reports German nova-Institute.
Reprogrammed pancreatic cells cure type I diabetes
Latest NewsSwiss researchers have demonstrated a way to cure type I diabetes without cell transplantation. In model mice the reprogrammed non-islet cells from human pancreas
Sanofi appoints Ameet Nathwani
AppointmentsSanofi has appointed Ameet Nathwani, M.D. as Chief Digital Officer in addition to his current role of Executive Vice President, Chief Medical Officer.
Afyren raises €21m to launch production plant
Latest NewsFrench industrial biotech company Afyren announced a capital increase of €21m in a financing round led by Sofinnova Partners and Valquest Partners to scale up its biobased organic acid production to industrial scale.
Race against time
BackgroundAfter a quick start out the gates in 2012, the European Commission proceeded to carry out a lengthy review of its bioeconomy strategy – slamming the brakes on investor interest in EU biotechs developing solutions for the move to a low-carbon, zero-waste economy. Following several reports that suggested the bloc will miss internationally agreed sustainability targets, the EC now wants to speed up the switch to biobased production. Industry stakeholders presented a huge range of promising technologies at the EFIB, but are still awaiting the go-ahead.
Industrial biotech hub validates start-up ideas
Latest News